Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Function-Preserving Stereotactic Body Radiotherapy for Clinical State I-III Prostate Cancer

NCT02334579 is registered in ClinicalTrials.gov with Swedish Medical Center as lead sponsor.

NCT NCT02334579
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02334579 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Function-Preserving Stereotactic Body Radiotherapy for Clinical State I-III Prostate Cancer
Lead sponsor
Swedish Medical Center
Phase
Not applicable
Overall status
Unknown status
Start date
December 31, 2014
Completion date
December 31, 2024
Enrollment
146 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cancer of the prostate, prostate cancer, prostate neoplasms, prostatic cancer, prostatic neoplasms